Nexus (NXU) Q2 2025 earnings summary

Executive summary

• Sales rose 10.3% year-over-year to KEUR 140,763 in H1 2025, with strong growth in Germany and key segments.

• EBIT increased 32.8% to KEUR 21,797, and net income grew 25.9% to KEUR 15,590 compared to H1 2024.

• Major acquisitions and new orders, especially in digital healthcare and AI, expanded the product portfolio and market reach.

• Shareholder structure changed significantly after a takeover offer, with delisting expected.

Financial highlights

• EBITDA up 22.8% to KEUR 31,239; EBITA up 29.8% to KEUR 25,243 year-over-year.

• Earnings per share increased 27.8% to EUR 0.92.

• Cash flow from operating activities rose 34.3% to KEUR 37,089.

• Liquid assets including short-term deposits reached KEUR 136,819, up 20% from year-end 2024.

• Share price closed at EUR 71.90 on 30/06/2025, up 31.7% year-over-year.

Outlook and guidance

• Management expects continued growth, with focus on business process optimization and integration of acquisitions.

• Promising pipeline of new orders and tenders, with further acquisition opportunities anticipated.

• Annual targets reaffirmed despite challenges from shareholder changes and market dynamics.